Trial intelligence / Profile preview

Etomidate vs propofol for sedation during gastric endoscopic submucosal dissection

KCT0007295Phase 4Recruiting

Sponsor
Korea University Anam Hospital
Start
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in gastric cancer (GC) comparing Etomidate arm with Propofol arm (2 arms). Started Jun 2022; status: recruiting.

02

Drugs

etomidatepropofol
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on KCT0007295.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0007295.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call